Form 5500 · Employee benefit plan · HUMACAO, PR
GALEPHAR PHARMACEUTICAL RESEARCH, INC.
GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s employee benefit plan is documented in its annual Form 5500 filing with the Department of Labor. Its broker of record is IKON INSURANCE, INC.. Coverage is written through TRIPLE S VIDA. The plan's most recent policy period ended in December.
Sourced from U.S. DOL EFAST2 Form 5500 · EIN 66-0565645 · plan 502 · as of Jul 2026
Schedule A insurance contracts
| Carrier | Benefits | Covered | Renews | Commission |
|---|---|---|---|---|
| TRIPLE S VIDA | Disability | 15 | December | $3,953 |
Questions
Who is GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s benefits broker?
Per its most recent Form 5500 Schedule A, GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s broker of record is IKON INSURANCE, INC..
What insurance carrier does GALEPHAR PHARMACEUTICAL RESEARCH, INC. use?
GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s benefit plan is written through TRIPLE S VIDA.
When does GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s group plan renew?
The most recent Schedule A policy period for GALEPHAR PHARMACEUTICAL RESEARCH, INC. ended in December. Group plans typically renew on the same annual cycle.
Where does this data come from?
All figures are drawn from GALEPHAR PHARMACEUTICAL RESEARCH, INC.'s public Form 5500 filing with the U.S. Department of Labor (EFAST2). Form 5500 is a public record.